We audited the accuracy of the Systemic Anti-Cancer Therapy dataset as a resource for rapid analysis of outcomes for patients, in this example, receiving Cancer Drug Fund funded monoclonal antibodies to treat metastatic colorectal cancer. We concluded that the Systemic Anti-Cancer Therapy dataset is a potentially valuable resource for rapidly determining survival outcome for patients treated with chemotherapy.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.clon.2017.02.011 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!